Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -878.6 Million MYR | -418.65% |
| 2022 | 275.72 Million MYR | -96.45% |
| 2021 | 7.76 Billion MYR | 336.49% |
| 2020 | 1.77 Billion MYR | 387.61% |
| 2019 | 364.67 Million MYR | -14.96% |
| 2018 | 428.83 Million MYR | 29.69% |
| 2017 | 330.66 Million MYR | -8.33% |
| 2016 | 360.72 Million MYR | 28.93% |
| 2015 | 279.78 Million MYR | 54.98% |
| 2014 | 180.52 Million MYR | -8.13% |
| 2013 | 196.5 Million MYR | -3.07% |
| 2012 | 202.72 Million MYR | 79.26% |
| 2011 | 113.09 Million MYR | -53.88% |
| 2010 | 245.23 Million MYR | 44.99% |
| 2009 | 169.13 Million MYR | 53.67% |
| 2008 | 110.06 Million MYR | 22.9% |
| 2007 | 89.56 Million MYR | 14.25% |
| 2006 | 78.39 Million MYR | 46.67% |
| 2005 | 53.44 Million MYR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 62.41 Million MYR | 257.71% |
| 2024 Q1 | -46.09 Million MYR | 89.76% |
| 2024 Q2 | -51.19 Million MYR | 14.13% |
| 2023 Q3 | -118.84 Million MYR | 22.42% |
| 2023 Q2 | -153.17 Million MYR | 2.2% |
| 2023 FY | -878.6 Million MYR | -418.65% |
| 2023 Q1 | -156.61 Million MYR | -205.62% |
| 2023 Q4 | -449.97 Million MYR | -278.64% |
| 2022 Q4 | -51.24 Million MYR | -285.08% |
| 2022 Q2 | 87.54 Million MYR | -52.86% |
| 2022 Q1 | 185.71 Million MYR | -58.49% |
| 2022 FY | 275.72 Million MYR | -96.45% |
| 2022 Q3 | 27.68 Million MYR | -68.37% |
| 2021 Q4 | 447.4 Million MYR | -78.03% |
| 2021 Q3 | 2.03 Billion MYR | -29.03% |
| 2021 Q2 | 2.86 Billion MYR | 21.68% |
| 2021 Q1 | 2.35 Billion MYR | 100.22% |
| 2021 FY | 7.76 Billion MYR | 336.49% |
| 2020 Q3 | 347.89 Million MYR | 200.73% |
| 2020 Q4 | 1.17 Billion MYR | 238.49% |
| 2020 Q1 | 111.42 Million MYR | 50.24% |
| 2020 FY | 1.77 Billion MYR | 387.61% |
| 2020 Q2 | 115.68 Million MYR | 3.82% |
| 2019 Q1 | 110.05 Million MYR | 7.7% |
| 2019 Q2 | 105.79 Million MYR | -3.87% |
| 2019 Q3 | 74.66 Million MYR | -29.42% |
| 2019 FY | 364.67 Million MYR | -14.96% |
| 2019 Q4 | 74.16 Million MYR | -0.67% |
| 2018 Q3 | 117.57 Million MYR | 7.85% |
| 2018 Q4 | 102.18 Million MYR | -13.08% |
| 2018 Q2 | 109.01 Million MYR | 3.38% |
| 2018 Q1 | 105.44 Million MYR | 11.6% |
| 2018 FY | 428.83 Million MYR | 29.69% |
| 2017 Q1 | 73.31 Million MYR | 12.24% |
| 2017 FY | 330.66 Million MYR | -8.33% |
| 2017 Q4 | 94.48 Million MYR | 21.59% |
| 2017 Q3 | 77.71 Million MYR | -6.43% |
| 2017 Q2 | 83.05 Million MYR | 13.28% |
| 2016 FY | 360.72 Million MYR | 28.93% |
| 2016 Q1 | 128.34 Million MYR | 24.91% |
| 2016 Q3 | 62.45 Million MYR | -40.29% |
| 2016 Q4 | 65.31 Million MYR | 4.58% |
| 2016 Q2 | 104.6 Million MYR | -18.5% |
| 2015 Q4 | 102.75 Million MYR | 42.17% |
| 2015 Q3 | 72.27 Million MYR | 28.9% |
| 2015 Q2 | 56.06 Million MYR | 15.17% |
| 2015 FY | 279.78 Million MYR | 54.98% |
| 2015 Q1 | 48.68 Million MYR | 5.1% |
| 2014 Q3 | 42.37 Million MYR | 1.97% |
| 2014 Q2 | 41.55 Million MYR | -17.35% |
| 2014 Q1 | 50.27 Million MYR | 3.83% |
| 2014 FY | 180.52 Million MYR | -8.13% |
| 2014 Q4 | 46.31 Million MYR | 9.31% |
| 2013 FY | 196.5 Million MYR | -3.07% |
| 2013 Q2 | 50.31 Million MYR | -12.48% |
| 2013 Q4 | 48.42 Million MYR | 20.24% |
| 2013 Q1 | 57.49 Million MYR | -10.21% |
| 2013 Q3 | 40.27 Million MYR | -19.96% |
| 2012 Q3 | 53.81 Million MYR | 0.66% |
| 2012 FY | 202.72 Million MYR | 79.26% |
| 2012 Q1 | 31.43 Million MYR | 20.73% |
| 2012 Q2 | 53.45 Million MYR | 70.07% |
| 2012 Q4 | 64.02 Million MYR | 18.99% |
| 2011 Q3 | 25.59 Million MYR | 0.74% |
| 2011 Q4 | 26.03 Million MYR | 1.71% |
| 2011 Q2 | 25.41 Million MYR | 0.0% |
| 2011 FY | 113.09 Million MYR | -53.88% |
| 2010 FY | 245.23 Million MYR | 44.99% |
| 2009 FY | 169.13 Million MYR | 53.67% |
| 2008 FY | 110.06 Million MYR | 22.9% |
| 2007 FY | 89.56 Million MYR | 14.25% |
| 2006 FY | 78.39 Million MYR | 46.67% |
| 2005 FY | 53.44 Million MYR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -94690.661% |
| Ansell Limited | 76.5 Million USD | 1248.507% |
| Ansell Limited | 76.5 Million USD | 1248.507% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 3718.619% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | -53794.297% |
| Psykey, Inc. | -1.32 Million USD | -66262.577% |
| ConvaTec Group Plc | 130.3 Million USD | 774.296% |
| ConvaTec Group Plc | 130.3 Million USD | 774.296% |
| Encision Inc. | -691.78 Thousand USD | -126906.301% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -619462.657% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -374787.142% |
| Innovative MedTech Inc. | -7.93 Million USD | -10967.129% |
| LifePoint, Inc. | -15.23 Million USD | -5668.325% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | -12799.838% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -185260.338% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -320038.752% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -191306.189% |
| SmileDirectClub, Inc. | -86.4 Million USD | -916.86% |
| Sector 10, Inc. | 7036.00 USD | 12487422.342% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 143.889% |
| SheerVision, Inc. | -71.37 Thousand USD | -1230857.184% |
| United Health Products, Inc. | -2.62 Million USD | -33392.893% |
| Vasamed, Inc. | -4.88 Million USD | -17874.233% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | -36685.436% |
| Yubo International Biotech Limited | -1.2 Million USD | -72827.749% |